AZAANTHRACENEDIONES AS ANTITUMOR AGENTS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 7140
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1987
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Po Box 325, North Haven, CT, 06473
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 DONALD H BROWNING
 (203) 281-0012
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE OBJECTIVE OF THIS PROPOSAL IS AN INTEGRATION OF A CHEMICAL AND BIOLOGICAL APPROACH TO THE COMMERCIAL DEVELOPMENT OF A NEW HETEROCYCLIC ANTITUMOR AGENT. HUMPHREYCHEMICAL COMPANY PROPOSES TO SYNTHESIZE AND BIOLOGICALLY EVALUATE A SERIES OF AZAANTHRACENE-9,10-DIONES. THE GOAL IS THE COMMERCIALIZATION OF AN ANTITUMOR AGENT THAT LACKS THE INHERENT CARDIOTOXICITY CURRENTLY EXHIBITED BY ANTINEOPLASTIC AGENTS SUCH AS MITOXANTRONE.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government